The gene editing technology developer is the latest spinout emerging out of the lab of David Liu at Broad Institute.

Imperative Care boosted its total funding to at least $379m, with Ascension Ventures participating in the stroke care technology provider's series D round.

Alexandria Venture Investments was among the participants in a series B round for Wugen, which is developing cellular therapeutics for cancer.

SoftBank Vision Fund 2 led a series C round for the driver safety technology developer at a valuation of almost $1bn that also featured M12.

FedEx Express has provided the shipping and logistics service provider with fresh funding which will boost its pick-up and delivery services across India.

Patient Square Capital led a series B round for the gene therapy developer that included existing corporate investor Dexcel Pharma.

The Berliner Volksbank-backed digital wealth manager has captured new funding in a round led by asset manager LGT.

Patient Square Capital has led a series B round for the Stanford-linked gene therapy developer, which previously collected $80.5m in May last year.

Alibaba and SAIC Motor helped provide fresh funding for the in-car system provider having formed it as a joint venture in 2015.

Softbank helped the XDR cybersecurity software provider secure crossover financing at a valuation likely to have exceeded $3bn.